Angiotensin-IV-derived experimental peptidomimetic
PRODUCT PROFILE
Dihexa
£66.00
Dihexa is angiotensin-iv-derived experimental peptidomimetic. Researchers examine it in relation to synaptogenesis, cognitive decline and neuronal-connectivity models.
Why it is distinct
HGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
- Evidence stageExperimental
- AvailabilityUnavailable
- Batch recordPublished after verification
- DispatchConfirmed at checkout
Out of stock
Ask about availabilityPRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
Dihexa is angiotensin-iv-derived experimental peptidomimetic. Researchers examine it in relation to synaptogenesis, cognitive decline and neuronal-connectivity models.
Research focus+
Researchers investigate whether it can encourage new connections between nerve cells and support learning or memory. Evidence is mainly preclinical and human safety is not established.
How the mechanism differs+
Reported preclinically to potentiate hepatocyte growth factor/c-Met signalling and synapse formation.
Evidence and limitations+
Preclinical laboratory material with no credible controlled human efficacy or safety evidence.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers investigate whether it can encourage new connections between nerve cells and support learning or memory. Evidence is mainly preclinical and human safety is not established.
Reported preclinically to potentiate hepatocyte growth factor/c-Met signalling and synapse formation.
HGF/c-Met synaptogenesis hypothesis, unlike Semax’s neurotrophic ACTH-fragment lineage.
Preclinical laboratory material with no credible controlled human efficacy or safety evidence.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Early human evidence
DSIP
£13.995 mgBatch file pendingSleep is its historical research label, but mechanistic certainty is much lower than for receptor-defined peptides.
UnavailableAsk about availability -
Experimental
Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Experimental
P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Early human evidence
Selank
Price range: £34.99 through £52.9910 mgBatch file pendingTuftsin-derived and primarily anxiolytic/neuroimmune in focus, unlike the ACTH-derived Semax.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page